Generex Participating on Expert Panel for Fierce Pharma & Fierce Healthcare Corona Virus Virtual Series Dr. Eric von Hofe, PhD, Chief Scientific Officer of NuGenerex Immuno-Oncology to Speak on the Race to Develop a SARS-CoV-2 Vaccine Monday March 30, 2020 at 3 PM
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.